Advertise with us
[March 12, 2013]
RGDX, FOLD, EXXI, KBR, ORBC, OB Are Seasonally Ripe To Go Down In the Next Five Weeks
Mar 12, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Response Genetics Inc (NASDAQ:RGDX), Amicus Therapeutics Inc (NASDAQ:FOLD), Energy XXI (Bermuda) Ltd (NASDAQ:EXXI), KBR INCORPORATION (NYSE:KBR), ORBCOMM Inc (NASDAQ:ORBC), OneBeacon Insurance Group Ltd (NYSE:OB) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date RGDX Response Genetics Inc -5.79% 100.00% (5 of 5) Monday, March 18th 2013 FOLD Amicus Therapeutics Inc -4.16% 100.00% (5 of 5) Monday, March 18th 2013 EXXI Energy XXI (Bermuda) Ltd -2.79% 100.00% (5 of 5) Wednesday, March 13th 2013 KBR KBR INCORPORATION -1.76% 66.67% (4 of 6) Wednesday, March 13th 2013 ORBC ORBCOMM Inc -4.16% 100.00% (6 of 6) Thursday, March 14th 2013 OB OneBeacon Insurance Group Ltd -4.07% 66.67% (4 of 6) Friday, March 15th 2013 Response Genetics Inc (NASDAQ:RGDX) - Response Genetics, Inc., a life science company, engages in the research, development, marketing, and sale of pharmacogenomic tests for use in the treatment of cancer primarily in the United States, Asia, and Europe. The company develops genetic tests that measure predictive factors for tumor response in tumor tissue samples. It offers tests for non-small cell lung cancer, colorectal cancer, and gastric and gastroesophageal, and melanoma cancer patients tumor tissue specimens through its ResponseDX: Lung, ResponseDX: Colon, and ResponseDX: Gastric test suites, as well as under the ResponseDX: Melanoma name. The company also develops diagnostic tests for other types of cancer that identify genetic profiles of tumors, which recur after surgery; and engages in identifying genetic profiles of tumors, which are responsive to a particular chemotherapy. It serves community based oncologists, pathologists, physician offices, and hospitals, as well as pharmaceutical companies and research organizations through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California..
Amicus Therapeutics Inc (NASDAQ:FOLD) - Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of lysosomal storage disorders and diseases of neurodegeneration. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, enhance the stability of the protein, help it fold into the three-dimensional shape, as well as allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company focuses on the development of pharmacological chaperone monotherapy programs and pharmacological chaperones in combination with enzyme replacement therapy (ERT). Its pharmacological chaperone monotherapy programs for genetic diseases include migalastat HCl, which is in Phase III clinical trial for the treatment of Fabry disease; and AT3375, which is in preclinical stage for the treatment of Parkinson s disease. The company s pharmacological chaperone-ERT combination programs comprise Migalastat HCl co-administered with ERT for patients with Fabry disease receiving ERT treatment with any genetic mutation; AT2220 (duvoglustat HCl) co-administered with ERT for Pompe disease; AT3375 and afegostat tartrate co-administered with ERT for Gaucher disease; and pharmacological chaperone programs for other lysosomal storage diseases. Amicus Therapeutics, Inc. has a license and collaboration agreement with Glaxo Group Limited to develop and commercialize migalastat HCl. The company was founded in 2002 and is based in Cranbury, New Jersey..
Energy XXI (Bermuda) Ltd (NASDAQ:EXXI) - Energy XXI (Bermuda) Limited, together with its subsidiaries, engages in the acquisition, exploration, development, production, and operation of oil and natural gas properties onshore in Louisiana and Texas, and offshore in the Gulf of Mexico. As of June 30, 2012, the company s estimated net proved reserves were 119.6 million BOE. It operated or had an interest in 450 gross producing wells on 239,502 net developed acres, including interests in 41 producing fields. The company was founded in 2005 and is based in Hamilton, Bermuda..
KBR INCORPORATION (NYSE:KBR) - KBR, Inc. operates as an engineering, construction, and services company worldwide. The company s Hydrocarbons segment designs and constructs liquefied natural gas and gas-to-liquids facilities; and delivers onshore and offshore oil and natural gas production facilities, including platforms, floating production and subsea facilities, and pipelines. This segment also offers specialty consulting services, which include field development studies and planning, structural integrity management, and proprietary designs for ship and semi-submersible hulls; and executes projects and complexes, and licenses process technologies for the coal monetization, petrochemical, refining, chemicals, biofuels, and syngas markets. Its Infrastructure, Government, and Power segment offers base operations, facilities management, border security, engineering, procurement, construction (EPC) services, and logistics support to industrial commercial, defense, and governmental agencies; and project management, construction management, design, and support services for aviation, road, rail, maritime, water, waste water, building, and pipeline projects. It also offers a range of front-end engineering and design (FEED), pre-FEED, and EPC services to the heavy industrial and manufacturing clients; EPC management services; and EPC services for fossil fuel and renewable power generation, plant re-powering, and emissions control projects. The company s Services segment provides construction, construction management, fabrication, operations/maintenance, commissioning/startup, and turnaround services for the oil and gas, petrochemicals processing, mining, power, alternate energy, pulp and paper, industrial and manufacturing, and consumer product industries. Its Other segment includes the ventures business that invests in defense equipment and housing, toll roads, and petrochemicals projects. The company was founded in 1901 and is headquartered in Houston, Texas..
ORBCOMM Inc (NASDAQ:ORBC) - ORBCOMM Inc., a wireless data communications company, operates commercial wireless messaging system optimized for narrowband data communications primarily in the United States and Japan. The company s services enable businesses and government agencies to track, monitor, control, and communicate with fixed and mobile assets. It also provides customers with technology to monitor, manage, and remotely control refrigerated transportation assets. The company provides these services through a constellation of 27 low-Earth orbit or LEO satellites, 2 AIS microsatellites, and accompanying ground infrastructure. In addition, it offers terrestrial-based cellular communication services through reseller agreements with cellular wireless providers. The company markets and sells its products and services directly to original equipment manufacturers, government customers, and end-users, as well as through value-added resellers, international value-added resellers, international licensees, and country representatives. It serves various markets, such as commercial transportation, heavy equipment, fixed asset monitoring, marine vessels, and refrigerated transportation, as well as government and homeland security/Automatic Identification System. As of December 31, 2011, the company had approximately 648,000 billable subscriber communicators. ORBCOMM Inc. was founded in 2001 and is headquartered in Fort Lee, New Jersey..
OneBeacon Insurance Group Ltd (NYSE:OB) - OneBeacon Insurance Group, Ltd. operates as a property and casualty insurance writer focused on specialty lines. Its businesses include International Marine Underwriters, which offers ocean marine insurance; OneBeacon Technology Insurance that provides property, general liability, business auto, commercial umbrella, workers compensation, international, technology errors or omissions, data privacy, and communications liability policies for the technology sector; OneBeacon Accident Group, which offers accidental death and dismemberment, occupational and sports accident, vehicle physical damage, and other accident coverage; OneBeacon Government Risks, which offers property, casualty, and professional liability products to publicly funded agencies; and OneBeacon Energy Group property, which offers inland marine, casualty, general liability, auto liability, and umbrella liability insurance primarily to energy businesses. The company s businesses also comprise OneBeacon Professional Insurance, which offers professional liability solutions; OneBeacon Property and Inland Marine that provides monoline property and inland marine products; OneBeacon Specialty Property, which provides excess property and inland marine solutions; and OneBeacon Excess and Surplus, which offers insurance products in the excess and surplus market. In addition, its businesses include Collector Cars and Boats that provides coverage for collectible vehicles and wooden boats, automotive museums, and restoration shops; A.W.G. Dewar, which offers tuition reimbursement insurance; and OneBeacon Entertainment that provides commercial insurance for entertainment, sports, and leisure industries. OneBeacon Insurance sells its products through a network of independent agents, regional and national brokers, and wholesalers in the United States. The company was founded in 1831 and is headquartered in Minnetonka, Minnesota. OneBeacon Insurance Group, Ltd. is a subsidiary of White Mountains Insurance Group, Ltd..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk email@example.com www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
on the world wide web. Inquiries to firstname.lastname@example.org.
Back To NFVZone's Homepage